Ultrasound/Gastrointestinal Series: Contrast Agents in US

Abstract Archives of the RSNA, 2009

VG21

Ultrasound/Gastrointestinal Series: Contrast Agents in US

Multisession Courses — Gastrointestinal Radiology, Ultrasound,

Presented on November 30, 2009

Participants

Stephanie R. Wilson MD, Presenter: Research grant, Lantheus Medical Imaging, Inc, Billerica, MA Advisory Board, Koninklijke Philips Electronics NV , Bothel, WA Advisory Board, Siemens AG, Mountainview, CA

Sub-Events

VG21-01	Microbubble Contrast Agents: What Are They, and How Do They Work? Peter Burns BSc, PhD
VG21-02	Ultrasonographic Evaluation of Inflammatory Activity in Crohns Disease: Importance of Contrast Enhancement Vincenzo Migaleddu MD \| Roberto Prost MD \| Danilo Sirigu MD \| Domenico Scanu MD \| Giuseppe Virgilio MD \| Gerolamo Campisi MD
VG21-03	Quantitative Assessment of Bowel Wall Vascularization in Crohns Disease with Contrast-enhanced Ultrasound and Perfusion Analysis Ernst Michael Jung MD \| Stefan Feuerbach MD \| Andreas Schreyer MD \| Dirk-Andre Clevert MD \| Doris Schacherer MD, PhD \| Christina Gierlich MD, PhD
VG21-04	Comparison of Contrast-enhanced Ultrasonography and MRI in Displaying Anatomic Features of Pancreatic Serous Cystoadenomas Mirko D'onofrio MD \| Niccolo Faccioli MD \| Giovanni Foti MD \| Marco Barillari \| Roberto Pozzi-Mucelli MD
VG21-05	Micro Flow Imaging of Chronic Liver Disease for Assessment of Liver Fibrosis with Contrast-enhanced Sonography: Preliminary Experience Fuminori Moriyasu MD, PhD \| Junji Shiraishi \| Katsutoshi Sugimoto \| Shigeki Ichimura \| Ryou Metoki MD \| Kunio Doi PhD
VG21-06	Contrast-enhanced US of Benign Liver Tumors Tae Kyoung Kim MD
VG21-07	Contrast-enhanced Ultrasound of Regenerative Nodules and Dysplastic Nodules with Focus HCC in Liver Cirrhosis Min Hua Chen MD \| Wei Wu PhD \| Kun Yan BS
VG21-08	Contrast-enhanced Ultrasound (CEUS) in the Assessment of Cystic and Cystic-like Focal Liver Lesions (FLLs) Antonio Nunziata MD \| Orlando Catalano \| Sergio Venanzio Setola MD \| Alfredo Siani MD \| Fabio Sandomenico MD
VG21-09	Indeterminate Hepatic Lesions Detected at 64-slice MDCT in Patients with Gastrointestinal Tumor: May CEUS Be Effective as Problem-solving Imaging Modality? Vito Cantisani MD \| Chiara Marigliano \| Isabella Guerrisi \| Paolo Ricci MD \| Roberto Passariello MD \| Ugo D'Ambrosio MD
VG21-10	Contrast-enhanced US of Malignant Liver Tumors Hyun-Jung Jang MD
VG21-11	Real-Time Contrast-enhanced Ultrasonography-guided Biopsy of Focal Hepatic Lesions Not Localized at B-mode Ultrasonography Tae Kyoung Kim MD \| Kyoung Ho Lee MD \| Young Hoon Kim \| Soon Ho Yoon MD \| So Yeon Kim
VG21-12	Dynamic Contrast-enhanced Ultrasonography (DCE-US) with Quantification for the Early Evaluation of HCC Treated by Bevacizumab: Which Parameters? Serge Koscielny \| Nathalie Lassau MD, PhD \| Mohamed Chebil MD \| Linda Chami MD \| Riad Bendjilali MD \| Alain Roche MD
VG21-13	Contrast-enhanced US for Radiofrequency Ablation: Guidance and Monitoring of Therapy Luigi Solbiati MD
VG21-14	Pseudo-enhancement within Local Ablation Zone of Hepatic Tumors due to Nonlinear Artifact on Contrast-enhanced Ultrasound Peter Burns BSc, PhD \| Korosh Khalili MD \| Tae Kyoung Kim MD \| Hyun-Jung Jang MD \| Hojun Yu

Cite This Abstract

Wilson, S, Ultrasound/Gastrointestinal Series: Contrast Agents in US. Radiological Society of North America 2009 Scientific Assembly and Annual Meeting, November 29 - December 4, 2009 ,Chicago IL. http://archive.rsna.org/2009/8000427.html